First Page | Document Content | |
---|---|---|
Pharmacology Clinical research Epoxides Pfizer Tiotropium bromide Chronic obstructive pulmonary disease Acute exacerbation of chronic obstructive pulmonary disease Placebo Respimat Medicine Health Pulmonology | Amendment to NDA[removed], S-029Add to Reading ListSource URL: www.fda.govDownload Document from Source WebsiteFile Size: 2,59 MBShare Document on Facebook |